Low Dose Rituximab in Chronic ITP: Still an Option in Resource Limited Settings
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/article/10.1007/s12288-016-0764-x/fulltext.html
Reference20 articles.
1. Mueller-Eckhardt C (1977) Idiopathic thrombocytopenic purpura (ITP): clinical and immunologic considerations. Semin Thromb Hemost 3:125
2. Neunert C, Lim W et al (2011) The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 117(16):4190–4207
3. Moulis G, Sailler L (2014) Agne`s Sommet. Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity. Am J Hematol 89:41–46
4. Arnold DM, Dentali F, Crowther MA et al (2007) Systematic review: efficacy and safety of Rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med 146(1):25–33
5. Iacona I, Lazzarino M, Avanzini MA, Rupolo M, Arcaini L, Astori C et al (2000) Rituximab (IDEC-C2B8): validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study. Ther Drug Monit 22:295–301
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinical efficacy of two different doses of rituximab as a treatment option in adult patients with chronic immune thrombocytopenia;The Egyptian Journal of Internal Medicine;2024-06-11
2. Low‐dose rituximab plus high‐dose dexamethasone in newly diagnosed immune thrombocytopenia;European Journal of Haematology;2023-03-23
3. Rituximab Treatment for Severe Chronic Immune Thrombocytopenia in Children: A Report of 2 Cases and Literature Review;Advances in Clinical Medicine;2023
4. All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP;Blood;2022-01-20
5. Real-world Experience of Rituximab in Immune Thrombocytopenia;Indian Journal of Hematology and Blood Transfusion;2021-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3